Cargando…
The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine
Cardiovascular diseases (CVDs), encompassing ischaemic heart disease, cardiomyopathy, and heart failure, among others, are the most prevalent complications of diabetes and the leading cause of mortality in patients with diabetes. Cell death modalities, including apoptosis, necroptosis, and pyroptosi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637571/ https://www.ncbi.nlm.nih.gov/pubmed/37954843 http://dx.doi.org/10.3389/fphar.2023.1286718 |
_version_ | 1785133427059589120 |
---|---|
author | Zhang, Xiaobing Sun, Jing Wang, Jianying Meng, Tianwei Yang, Jianfei Zhou, Yabin |
author_facet | Zhang, Xiaobing Sun, Jing Wang, Jianying Meng, Tianwei Yang, Jianfei Zhou, Yabin |
author_sort | Zhang, Xiaobing |
collection | PubMed |
description | Cardiovascular diseases (CVDs), encompassing ischaemic heart disease, cardiomyopathy, and heart failure, among others, are the most prevalent complications of diabetes and the leading cause of mortality in patients with diabetes. Cell death modalities, including apoptosis, necroptosis, and pyroptosis, have been demonstrated to be involved in the pathogenesis of CVDs. As research progresses, accumulating evidence also suggests the involvement of ferroptosis, a novel form of cell death, in the pathogenesis of CVDs. Ferroptosis, characterised by iron-dependent lipid peroxidation, which culminates in membrane rupture, may present new therapeutic targets for diabetes-related cardiovascular complications. Current treatments for CVDs, such as antihypertensive, anticoagulant, lipid-lowering, and plaque-stabilising drugs, may cause severe side effects with long-term use. Traditional Chinese medicine, with its broad range of activities and minimal side effects, is widely used in China. Numerous studies have shown that active components of Chinese medicine, such as alkaloids, polyphenols, and saponins, can prevent CVDs by regulating ferroptosis. This review summarises the recent findings on the regulatory mechanisms of active components of Chinese medicine against ferroptosis in CVDs, aiming to provide new directions and a scientific basis for targeting ferroptosis for the prevention and treatment of diabetic CVDs. |
format | Online Article Text |
id | pubmed-10637571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106375712023-11-11 The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine Zhang, Xiaobing Sun, Jing Wang, Jianying Meng, Tianwei Yang, Jianfei Zhou, Yabin Front Pharmacol Pharmacology Cardiovascular diseases (CVDs), encompassing ischaemic heart disease, cardiomyopathy, and heart failure, among others, are the most prevalent complications of diabetes and the leading cause of mortality in patients with diabetes. Cell death modalities, including apoptosis, necroptosis, and pyroptosis, have been demonstrated to be involved in the pathogenesis of CVDs. As research progresses, accumulating evidence also suggests the involvement of ferroptosis, a novel form of cell death, in the pathogenesis of CVDs. Ferroptosis, characterised by iron-dependent lipid peroxidation, which culminates in membrane rupture, may present new therapeutic targets for diabetes-related cardiovascular complications. Current treatments for CVDs, such as antihypertensive, anticoagulant, lipid-lowering, and plaque-stabilising drugs, may cause severe side effects with long-term use. Traditional Chinese medicine, with its broad range of activities and minimal side effects, is widely used in China. Numerous studies have shown that active components of Chinese medicine, such as alkaloids, polyphenols, and saponins, can prevent CVDs by regulating ferroptosis. This review summarises the recent findings on the regulatory mechanisms of active components of Chinese medicine against ferroptosis in CVDs, aiming to provide new directions and a scientific basis for targeting ferroptosis for the prevention and treatment of diabetic CVDs. Frontiers Media S.A. 2023-10-26 /pmc/articles/PMC10637571/ /pubmed/37954843 http://dx.doi.org/10.3389/fphar.2023.1286718 Text en Copyright © 2023 Zhang, Sun, Wang, Meng, Yang and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, Xiaobing Sun, Jing Wang, Jianying Meng, Tianwei Yang, Jianfei Zhou, Yabin The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine |
title | The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine |
title_full | The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine |
title_fullStr | The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine |
title_full_unstemmed | The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine |
title_short | The role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional Chinese medicine |
title_sort | role of ferroptosis in diabetic cardiovascular diseases and the intervention of active ingredients of traditional chinese medicine |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637571/ https://www.ncbi.nlm.nih.gov/pubmed/37954843 http://dx.doi.org/10.3389/fphar.2023.1286718 |
work_keys_str_mv | AT zhangxiaobing theroleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT sunjing theroleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT wangjianying theroleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT mengtianwei theroleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT yangjianfei theroleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT zhouyabin theroleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT zhangxiaobing roleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT sunjing roleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT wangjianying roleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT mengtianwei roleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT yangjianfei roleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine AT zhouyabin roleofferroptosisindiabeticcardiovasculardiseasesandtheinterventionofactiveingredientsoftraditionalchinesemedicine |